Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Feb 18, 2021
|
staff reporter

NEW YORK (GenomeWeb) – Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues increased more than fivefold year over year due primarily to COVID-19 product sales.

For the three months ended Dec. 31, 2020 Quidel reported revenues of $809.2 million, up from $152.2 million in Q4 2019. The revenues were slightly above the analysts' consensus estimate of $809.1 million and consistent with the firm's preliminary earnings estimates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

What's Popular?

In COVID-19

  1. Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

  2. SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

  3. BioMérieux Reports 21 Percent Revenue Growth in Q4

  4. AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

  5. Thermo Fisher Scientific Sued by New Jersey Lab Over COVID-19 Testing Problems

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.